Article Versions Notes

Basilico N, Parapini S, D’Alessandro S, Misiano P, Romeo S, Dondio G, Yardley V, Vivas L, Nasser S, Rénia L, et al. Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities. Biomolecules. 2023; 13(5):836. https://doi.org/10.3390/biom13050836

Basilico, Nicoletta, Silvia Parapini, Sarah D’Alessandro, Paola Misiano, Sergio Romeo, Giulio Dondio, Vanessa Yardley, Livia Vivas, Shereen Nasser, Laurent Rénia, and et al. 2023. "Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities" Biomolecules 13, no. 5: 836. https://doi.org/10.3390/biom13050836

Basilico, N., Parapini, S., D’Alessandro, S., Misiano, P., Romeo, S., Dondio, G., Yardley, V., Vivas, L., Nasser, S., Rénia, L., Russell, B. M., Suwanarusk, R., Nosten, F., Sparatore, A., & Taramelli, D. (2023). Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities. Biomolecules, 13(5), 836. https://doi.org/10.3390/biom13050836